| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8660006 | Heart, Lung and Circulation | 2017 | 13 Pages |
Abstract
There is currently no data in Australia and New Zealand that CAC is cost-effective in informing primary prevention decisions. Given the cost of testing is currently borne entirely by the patient, discussion regarding the implications of CAC results should occur before CAC is recommended and undertaken.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gary MBBS, PhD, FRACP, Clara MBBS, PhD, FRACP, Niels MBChB, FRACP, John MB, BCh, FRACP, Michael MBBS, MD, FRACP, Jonathan MBBS, PhD, FRACP, Christian MBBS, PhD, FRACP,